HIMS launches multi-cancer screening blood test through GRAIL partnership
Go back to HIMS launches multi-cancer screening blood test through GRAIL partnership| (NYSE: HIMS) | Delayed: 27.00 -1.87 (6.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.87 | 52 Week High | $ | |||
| Open | $28.68 | 52 Week Low | $ | |||
| Day High | $27.30 | P/E | N/A | |||
| Day Low | $26.60 | EPS | $ | |||
| Volume | 14,528,623 | |||||

